Quick Answer
Marker Therapeutics, Inc. reported Total Revenue of $213.2 thousand for fiscal year 2019.
Marker Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2019 | $213.2K | +3.5% |
| 2018 | $206.0K | +12.5% |
| 2017 | $183.1K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2019 | $0.00 | — | — |
| June 30, 2019 | $0.00 | -100.0% | — |
| September 30, 2018 | $0.00 | -100.0% | -100.0% |
| June 30, 2018 | $206.0K | — | +12.5% |
| September 30, 2017 | $183.1K | — | — |
| June 30, 2017 | $0.00 | — | — |
- Marker Therapeutics, Inc. showed an increase of +3.5% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2019 period, Marker Therapeutics, Inc.’s total revenue has grown by 16.5% (from $183.1 thousand to $213.2 thousand).
- The most recent figure is from Marker Therapeutics, Inc.’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 12, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: